Inventor · disambiguated record
Ulf Neumann
Also filed as: NEUMANN ULF
3 granted patents·7 pending applications·4 citations·filing 2001–2020
53Inventor score
Top patents by PatentIndex Score
10 records- 0160US2015018338A1Oxazine derivatives and their use in the treatment of neurological disordersBADIGER SANGAMESH·Filed 2014·Application pending·0 cites
- 0259US6500983B2Hydroxamic acid derivativesNOVARTIS AG·Filed 2001·Granted Dec 31, 2002·4 cites·16 claims
- 0353US2020345746A1Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk PatentsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0446US2012172359A1Oxazine Derivatives and their Use in the Treatment of Neurological DisordersBADIGER SANGAMESH·Filed 2012·Application pending·0 cites
- 0544US2012302558A1Oxazine derivatives and their use in the treatment of neurological disordersBADIGER SANGAMESH·Filed 2011·Application pending·0 cites
- 0642US2020207830A1Trem2 mutants resistant to sheddase cleavageNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0740US10722518B2Oxazine derivative for use in the treatment or prevention of cerebral amyloid angiopathyNOVARTIS AG·Filed 2017·Granted Jul 28, 2020·0 cites·17 claims
- 0840US7589091B2Hydroxamic acid derivativesNOVARTIS AG·Filed 2003·Granted Sep 15, 2009·0 cites·12 claims
- 0940US2018036315A1Oxazine Derivative for Use in the Prevention of Alzheimer's Disease in at Risk PatientsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1033US2013281449A1Oxazine Derivatives and their Use in the Treatment of Neurological DisordersHURTH KONSTANZE·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →